Sartorius | SRT3 - Current Liabilities

Stock Price
208.30
Daily Change
-1.40 -0.67%
Monthly
-7.67%
Yearly
-15.84%
Q1 Forecast
203.68

Sartorius reported EUR1.81B in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Revvity USD 1.33B 108.5M Dec/2025
Sartorius EUR 1.81B 254.3M Sep/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025